Regional disparities in botulinum toxin A (BoNT‐A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap
P. Ertzgaard; M. Anhammer; A. Forsmark
Author Information: Department of Rehabilitation Medicine and Department of Medicine and Health Sciences (IMH)
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.